The most remarkable finding from this study is that the miR-22-3p/galectin-1 axis affects cancer progression by regulating the cell cycle in hormone receptor-positive breast cancers and by affecting EMT mechanisms in triple-negative breast cancers. This evidence concerns the gene NR4A1 and cancer.